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INTRODUCTION 
 
Electrocardiography (ECG) is an essential tool for diagnosis and 
management of patients with various cardiovascular (CV) diseases. With the 
development and increased availability of new imaging techniques, however, 
ECG has lost some of its diagnostic importance. In athletic screening, the 
usefulness of ECG is also controversial. In athletes, ECG changes are 
common, and in most cases these reflect benign structural and electrical 
remodeling of the heart due to physiological adaptation to exercise, a 
condition often referred to as “athlete’s heart”. However, the differential 
diagnosis between physiological changes and pathological abnormalities can 
be challenging. In Hungary, ECG is still a cornerstone of athletic screening. 
Its significance is based on simplicity, easy availability, short time to perform 
and interpret, and high informative value in special cases.  
However, the cornerstone is just part of any foundation, so additional test 
modalities are often necessary. With long-term, 24-hour ECG recordings we 
may not only catch transient arrhythmias and ischemia, but we can also get 
useful information about autonomic function and predict CV risk. In case of 
intact autonomic regulation, simultaneous and opposite changes of 
sympathetic and parasympathetic activity manifest in beat-to-beat 
fluctuations of heart rate (HR). Modern Holter monitoring systems are 
suitable to identify beat-to-beat perturbations of the normal RR intervals, 
called heart rate variability (HRV) analysis.  
On an exercise test, interpretation of the ST segments provides useful for its 
diagnostic information, but important prognostic value can be gained from 
variables such as functional aerobic capacity (FAC) and exercise HR 
responses. The prognostic predictive value of these parameters has been 
studied in a wide range of CV populations and has proved to be an 
independent powerful predictor of mortality.  
Cigarette smoking has profound effects on health with several disabling and 
life-shortening consequences. It reduces FAC and impairs the HR response 
to exercise, which are important early markers of CV risk. Smoking 
cessation, on the other hand, frequently leads to weight gain and weight-
associated comorbidites including hypertension and diabetes. The interplay 
between smoking status and the predictive exercise factors including FAC 
and HR recovery are of great potential importance in assessing risk and 
establishing the benefits of smoking cessation. 
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OBJECTIVES OF OUR STUDIES 
The purpose of our studies was to emphasize the importance of ECG in 
athletic screening, to show the additional diagnostic potential of long-term 
ECG recording in athletes, to conversely present the predictive value of non-
ECG factors on exercise test in an adult referral population and to define the 
role of FAC and HR responses in predicting risk according to smoking status. 
1. Our first aim was to study electrocardiographic adaptation to sports-
specific training.  
 We conducted a detailed prospective observational study of 
athletes in which we performed ECG analysis 
 We documented the prevalence of physiological ECG changes, 
potentially pathological ECG changes in a composite sample of 
healthy, asymptomatic Hungarian athletes.  
2. Our hypothesis was that training adaptation concomit autonomic 
nervous system adaptation, which can be determined by analysis of 
HRV during long-term Holter monitoring. 
 We measured HRV in our prospective cohort of asymptomatic elite 
and master athletes and controls during Holter ECG monitoring.  
 Our second aim was to study sport-specific differences in HRV.  
 Moreover, we targeted to determine normal distribution curves and 
lower cut-off values for the studied HRV parameters to provide the 
lower limit of normal athletic values in the elite athletes.  
3. Subsequently, we also analyzed a large cohort of adult, non-athletic 
patients without CV disease, who underwent clinical exercise testing.  
 Our aim was to determine factors including age, sex, 
cardiorespiratory fitness (CRF) and comorbidities that affect 
exercise HR. 
 After the exclusion of HR modifying factors we aimed to determine 
exercise HR responses in men and women according to age 
4. Finally, using our large exercise testing database with a fully ascertained 
total, CV, and cancer mortality during long-term follow-up 
 We proposed to study the effect of smoking on weight-associated 
comorbidities and mortality in patients without CV diseases.  
 We equally sought to determine whether better CRF on a stress test 
reduces mortality risk in past and current smokers. 
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METHODS 
Study Population of Athletic ECG Projects 
Healthy asymptomatic elite, non-elite and master athletes and controls were 
studied. Elite athletes were members of national teams, and they trained more 
than 10 hours per week. Masters were defined as athletes over 30 years of 
age who had been former national team members, were still participating in 
master championships and their amount of training was between 6 and 9 
hours per week. Healthy volunteers not participating in competitive sports 
composed the control group recruited from employees of Semmelweis 
University, mainly medical students and residents. Their physical activity 
was less than 3–4 hours per week according to the questionnaire mentioned 
above. The upper limit of training time during Holter monitoring was 
maximum 2 hours. Individuals were excluded if they had any history of heart 
disease, diabetes, or still existing systemic disease. 
Study Population of Exercise ECG Projects 
Patients who underwent exercise treadmill testing between September 21, 
1993, and December 20, 2010, were identified retrospectively using the 
Mayo Integrated Stress Center (MISC) database in Rochester, MN, USA.  
For our exercise HR project we included patients aged 40 to 89 years who 
had performed non-imaging treadmill tests according to the Bruce protocol. 
Exclusion criteria to define our preliminary cohort were: (1) documented 
history of known CV disease, including ischemic heart diseases, heart 
failure, cardiac surgery, structural or valvular heart diseases, major 
arrhythmias, defibrillator or pacemaker, congenital heart diseases, 
cerebrovascular diseases, and peripheral vascular diseases; (2) use of any HR 
attenuating or rhythm-modifying agents, including beta blockers, calcium 
channel blockers, sotalol, and amiodarone, at the time of the exercise test; 
(3) patients younger than 40 years because reasons for exercise testing in 
younger patients were different and the number of younger patients was 
relatively small; (4) the test was not symptom limited but stopped because of 
ST changes, major arrhythmias, or abnormal BP response; and (5) for 
patients who underwent multiple exercise tests during the study period, only 
the initial exercise test was included. For our smoking project the study 
population was basically the same, but we included patients older than 30 
years and we did not exclude patients using HR attenuating or rhythm-
modifying drugs.  
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Demographic and relevant clinical characteristics extracted from the 
database included hypertension (defined by previous diagnosis or receiving 
antihypertension medication), diabetes mellitus (defined by previous 
diagnosis), obesity (defined as body mass index of 30 kg/m2), and current 
smoking. Smoking status was defined according to the Centers for Disease 
Control (CDC) definitions. Never smokers have not smoked 100 cigarettes 
in their lifetime and do not smoke now.  A smoker was considered past 
smoker if smoked at least 100 cigarettes but does not smoke any now.  
Current smokers have smoked at least 100 cigarettes in their lifetime and 
currently smoke. We also identified patients who were grossly unfit or 
unable to exercise adequately as having a FAC of < 80%. Patients were 
divided into 3 groups by smoking status, and then these groups were sub-
divided into 3 groups according to CRF based on FAC on the exercise test: 
poor CRF < 80%, reduced CRF 80 – 99%, normal CRF ≥ 100%. 
Ethical approval for the Hungarian research projects was obtained from the 
Central Ethics Committee of Hungary (13697-1/2011-EKU[443/PI/11.]) and 
all participants gave informed consent. Exercise ECG investigations were a 
retrospective database studies approved by the Institutional Review Board of 
Mayo Clinic, Rochester, Minnesota. Subjects who did not consent to have 
their data used in research under Minnesota Statue (§144.335) were 
excluded.  
Measurements  
Athletes 
Resting 12- lead ECG 
Standard resting 12-lead ECGs were recorded (BTL – 08MT). Detailed ECG 
analysis was performed using the 2010 recommendations for ECG 
interpretation of athletes by the European Society of Cardiology. 
Holter ECG 
Three-channel Holter ECG screening was applied (ScottCare Cardioview 
DxSuite, USA) using modified V5, V1 and III leads. Automatic HRV 
analysis was carried out using software HolterCare ver. 10.2.2. After the 
automatic analysis, all recordings were examined by a physician to verify 
premature beats and artifacts. During the test the participants were asked to 
do their daily routine as usual, including training, food intake and sleeping.  
Holter ECG Variables 
Short- and long-term time-domain parameters were studied excluding 
premature and artifacts beat as follows: (1) The standard deviation of all 
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normal-to-normal intervals (SDNN), which is a global index of HRV 
reflecting all circadian changes during the whole recording period. It 
characterizes the overall variability of HR, which means it can be influenced 
both by parasympathetic and sympathetic stimulation. (2) The mean of the 
5-min standard deviation of the normal-to-normal intervals (SDNN Index), 
which measures the variability of 5-min cycles. It integrates the fast and 
intermediate components of HRV. (3) The square root of the mean squared 
differences between adjacent NN intervals (RMSSD) and (4) the percentage 
of successive normal-to-normal interval differences that are greater than 50 
ms (pNN50) primarily reflects the parasympathetically mediated short-term 
alterations of autonomic tone.  
 
Non-Athletes 
Exercise Treadmill Test Protocol 
Symptom-limited treadmill exercise testing was performed using the 
standard Bruce protocol according to the ACC/AHA guidelines. Symptoms, 
BP, HR, rating of perceived exertion (RPE), and workload were 
electronically entered into the database during the final minute of each stage 
of exercise, peak exercise, 1 and 3 minutes of active recovery, and 6 minutes 
after peak exercise in passive recovery.  
Exercise Treadmill Test Variables  
Exercise data used in analyses included percentage of predicted FAC 
calculated from published equations from our laboratory with adjustment for 
age and sex. Patients with an FAC of 80% were considered either grossly 
unfit or unable to exercise adequately to achieve peak HR. A positive 
exercise ECG was defined by standard criteria. An abnormal exercise ECG 
was defined as any test with 1.0 mm ST deviation irrespective of whether the 
resting ST segments were normal. Resting HR obtained in the standing 
position and peak HR were identified and used to calculate the HR reserve 
(difference between peak and resting HR). The HR recovery was defined as 
peak HR minus HR at 1 minute of active recovery (1.7 miles per hour/0% 
grade) and was considered abnormal if it was less than 12 beats/min.  
Outcomes 
Outcomes were taken from Mayo Clinic patient records and the Minnesota 
Death Index, which was reviewed in March, 2016. A death was considered 
to be CV-related if a CV condition was included among the first three listed 
causes in the Minnesota Death Index.  CV mortality data was classified using 
International Classification of Diseases (ICD) 9 and ICD 10 codes.   
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Statistical analyses 
Athletes (Research Aims 1-2) 
Age was compared using 2-sided t-test, while gender and ECG 
characteristics were compared using Fisher’s exact test. Differences between 
groups were evaluated using one-way analysis of variance. Differences 
between HRV parameters of the studied groups were assessed after 
normalizing square-root transformation by analysis of covariance with age 
as a covariate. Pairwise comparisons of age-corrected means were performed 
using Tukey–Kramer post hoc test. Normal distribution curves were fitted by 
square root transformation, and lower cut-off values were determined at 5 %.  
 
Non-Athletes (Research Aims 3-4) 
Statistical analyses proceeded in 2 parts: (1) create a preliminary cohort of 
patients without CV disease or drugs affecting HR and identify the 
comorbidities that influence peak HR and (2) determine the relationship 
between exercise HR and sex in a pure cohort with those comorbidities 
eliminated. Baseline characteristics and exercise test variables were 
compared by sex using 2-sided t tests for continuous variables and the chi-
square test of continuity for categorical variables. Analysis of variance using 
the general linear model was used to identify factors affecting peak HR with 
adjustment for sex and age. Factors included in the model were diabetes, 
hypertension, hyperlipidemia, obesity and unfit status (FAC<.05).  
Patient characteristics, outcomes, and exercise data were also analyzed by 
smoking status. Differences among continuous variables were assessed by 
analysis of variance under the general linear model with multiple 
comparisons handled by Tukey’s method, while logistic regression was used 
to determine differences in discrete variables by smoking status. For the 
primary analysis of smoking-related comorbidities - diabetes, hypertension, 
and obesity, logistic regression models were adjusted for age and sex. 
Differences among smoking groups in total, CV, and cancer death were 
tested using Cox proportional hazards regression with adjustment for age, 
sex and the three comorbidities. Finally, we also analyzed mortality by 
smoking status and level of CRF. Never smokers with normal CRF formed 
the referent group, then the differences between hazard ratios were tested 
within the groups. 
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RESULTS 
ELECTROCARDIOGRAPHIC FINDINGS 
Study Population 
Standard ECG screening was applied in 227 Caucasian athletes (male: 
180, age: 27.2 ± 8.7). Elite athletes (n = 155) including several 
members of the Hungarian Olympic team, masters (n = 16), non-elite 
athletes (n = 56) and 89 controls (male: 57, age: 28.1 ± 6.8) were 
examined. No difference was found in age between athletes and 
controls, but the rate of female gender was higher in controls. Athletes 
performed various sports, mainly kayaking and canoeing, water polo 
and rowing.  
Training-related Physiological ECG Findings  
According to our results, almost all athlete had at least one training-
related ECG sign. Sinus bradycardia, early repolarization and isolated 
voltage criteria of LVH were common and found more often in 
athletes compared to the control group (Table 1/A).  
Training-unrelated Pathological ECG Findings  
Some ECG signs considered pathological such as repolarization 
changes including T-wave abnormalities, ST-segment changes and 
signs of pathological LVH were found more often in athletes 
compared to the control group (Table I/B). In 15% of the athletes, we 
recorded T-wave inversion classified as pathological. In most cases, 
T-wave inversion occurred in adjacent inferior or V1–V3 leads. LVH 
considered pathological – mostly associated with T-wave inversion – 
was presented in more than 5% of the athletes while in no controls.  
All athletes who had any pathological ECG abnormality underwent 
our detailed cardiology exam including echocardiography and cardiac 
MR. We did not find any stuctural heart disease, therefore no athlete 
was disqualified.  
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Table 1. Incidence of physiological and pathological ECG changes.  
ECG findings 
Athletes Controls 
N % N % 
A. Physiological ECG Changes 
Sinus bradycardia 116 51.1** 12 13.5 
Early repolarization 146 64.3** 32 35.9 
LVH×  52 22.9** 7 7.8 
Incomplete RBBB 70 30.8 28 31.5 
1st degree AV block 25 11.0 6 6.7 
Junctional rhythm  2 0.9 1 1.1 
B. Pathological ECG Abnormalities 
T-wave changes 34 15.0* 5 5.6 
ST- segment changes 15 6.6* 1 1.1 
Pathological LVH 12 5.3* - - 
RV hypertrophy 6 2.6 1 1.1 
Atrial hypertrophy 6 2.6 1 1.1 
Left anterior hemiblock 5 2.2 1 1.1 
Left posterior hemiblock 3 1.3 - - 
Delta-wave 2 0.8 - - 
LBBB 1 0.4 - - 
RBBB 1 0.4 - - 
(× isolated voltage criteria) ** P < .005 versus controls, * P < .05 versus controls 
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HOLTER ECG FINDINGS 
Analysis by Study Intesity 
The Holter ECG screening was applied in 138 athletes – 121 elite and 17 
masters – (male 110, age 28.4 ± 8.3, recording time 21.3 ± 3.0 h) and 100 
healthy controls. No difference was found in recording time among the 
studied groups. Masters athletes were older than all the other groups. The 
ratio of males was higher in athlete groups compared to controls. All studied 
HRV parameters were higher in elite athletes compared to controls [SDNN 
(CI) 225.3 (216.2–234.5) versus 158.6 (150.2–167.1) ms (e.s.:1.43); SDNN 
Index (CI) 99.6 (95.6–103.7) versus 72.4 (68.7–76.2) ms (e.s.:1.32); pNN50 
(CI) 24.2 (22.2–26.3) versus 14.4 (12.7–16.3) % (e.s.: 0.96); RMSSD (CI) 
71.8 (67.6–76.2) versus 50.8 (46.9–54.8) ms (e.s.:0.96); P <.001] (Figure 1). 
All HRV parameters of masters were higher than controls. No difference 
could be found between HRV values of elite athletes and masters. No effect 
of gender on the studied HRV parameters could be established. 
Figure 1. HRV analysis in elite athletes, masters athletes 
and controls. a SDNN, b SDNN Index, c pNN50 (%), and 
d RMSSD. Representative diagrams of RR variability in 
individuals under different intensity training.  
## P < .001 versus control 
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Analysis by Sport 
Subgroup analysis by sports was carried out in cyclists + triathlonists  (n=20), 
canoe and kayak paddlers (n=42), waterpolo players (n=26), rowers (n=27), 
runners (n=13) and combat fighters (kick-boxers and thai boxers, n=10). 
Runners were older than all other studied sport groups as most of them were 
ultramarathon runners. The ratio of females was higher in the waterpolo 
group compared to canoe and kayak paddlers, rowers and cyclists + 
triathlonists. All studied age-corrected HRV parameters were the highest in 
canoe and kayak paddlers and cyclists + triathlonists and the lowest in 
runners (Figure 2). Canoe and kayak paddlers had higher SDNN Index: 
110.0 (103.1–117.2) versus 81.6 (71.0–92.9) ms (e.s.:1.33), pNN50: 27.7 
(24.2–31.4) versus 17.2 (12.5–22.7) ms (e.s.:1.00), and RMSSD values: 81.9 
(74.1–88.1) versus 54.4 (42.3–63.7) ms (e.s.:1.15), cyclists + triathlonists 
had higher SDNN index value than runners 103.8 (94.2–114.0) versus 81.6 
(71.0–92.9) ms (e.s.:1.05). 
 
Figure 2. Subgroup analysis by sport activities. a SDNN, b SDNN Index, c 
pNN50 (%), and d RMSSD. * P < 0.05 versus. running 
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Comparison of Lower Cut-off Values 
In the controls, the 5 % lower cut-off values were comparable to the 
published normal values (SDNN: 97.6 ms, SDNN Index 44.1 ms, pNN50 2.6 
%, RMSSD 24.6 ms). On the contrary, the normal distribution curves of all 
studied HRV parameters shifted to the right with substantially higher cut-off 
values in elite athletes (SDNN 147.4 ms, SDNN Index 66.6 ms, pNN50 9.7 
%, RMSSD 37.9 ms (Figure 3). 
Figure 3. Normal distribution curves and lower cut-off values of elite 
athletes and controls. a SDNN, b SDNN Index, c pNN50 (%), and d RMSSD. 
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EXERCISE TEST RESULTS 
Study Population 
Our cohort was derived from adults consecutively referred for exercise stress 
testing at Mayo Clinic, Rochester, between September 21, 1993, and 
December 20, 2010. We initially reviewed 105,220 exercise tests on 79,769 
unique patients. Of these, 37,010 met preliminary inclusion and exclusion 
criteria. 
Peak Heart Rate by Age in Men versus Women in the Preliminary 
Clinical Cohort  
To further examine the relationship between peak HR and age in men versus 
women, we separately plotted peak HR by age for men and women in the 
preliminary cohort of 37,010 patients (Figures 4, A and B). Using linear 
regression, lines predicting peak HR by age are shown in Figure 4, along 
with 90% CIs and the traditional line depicting 220 minus age. Note a large 
variance around the regression line in both sexes. The regression line more 
closely approximated 220 minus age in terms of both intercept and slope for 
men versus women.  
Analysis of Factors Affecting Peak Heart Rate  
Using multivariate regression on the preliminary cohort, comorbidities 
significantly affecting peak HR included poor exercise capacity (beta 
coefficient = - 11 beats/min), current smoking (-6 bpm), diabetes (-3 bpm), 
and obesity (-2 bpm). We excluded patients with these comorbidities to form 
the pure cohort of 19,013 patients (51.3% of full cohort). Peak HR was again 
plotted against age for men and women separately in Figures 4, C and D. 
The distribution of peak HR by age became tighter (with improved R2) after 
eliminating patients with modifying risk factors, and the regression lines 
more closely approximated the traditional 220 minus age formula. For men, 
the regression line in our pure cohort was peak HR = 221 - 0.95 x age. For 
women, it was peak HR = 210 - 0.79 x age, which was still substantially 
different from the traditional 220 minus age formula. Comparing  the 
relationship of peak HR to age between men with women in our pure cohort, 
both the regression slopes and intercepts were different at P<.0001. 
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Figure 4. Scatter plot diagrams of the peak HR on the preliminary, 
unadjusted clinical cohort by age in men (A) and women (B), and on the 
final, adjusted clinical cohort in men (C) and women (D). Results of linear 
regression are shown as continuous lines, with 90% CIs shown as broken 
lines, whereas the traditional formula of 220 minus age is shown as dotted 
lines.  
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Exercise Test Parameters by Age in Men versus Women in the 
Pure Clinical Cohort  
We divided the final data set into 5 age groups to analyze the effect of aging 
on HR parameters in men and women. All exercise HR parameters showed 
an inverse linear relationship to age in both sexes (Figure 5). Resting HR 
was higher in women than in men in all age groups. The HR reserve was 
lower in women than in men and showed continuously decreasing 
differences by successive age groups. In the 40 to 49 and 50 to 59 years age 
groups, significant differences were found in peak HR, but the curves crossed 
at the 60 to 69 years age group, and so older women had slightly higher peak 
HR than did men. Differences in HR recovery were small on comparing men 
and women, with a significant difference only in the age group 50 to 59 
years. 
Figure 5. Resting HR (A), HR reserve (B), peak HR (C), and HR recovery 
(D) by age in men versus women in the final cohort. Data points represent 
mean ± SD. Significance levels: *** P <.05, * P < .05. 
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Exercise Testing and Mortality Risk 
 
Comorbidities by Smoking Status 
For the next step of the analysis, logistic regression with age and sex 
adjustment was applied on comorbidities by smoking status to determine the 
risk of the presence of diabetes, obesity and hypertension according to 
smoking status (Figure 6). Past smokers had a greater prevalence of obesity, 
hypertension, and diabetes compared to never smokers. Current smokers did 
not show an increased prevalence of these comorbidities compared to never 
smokers.  
Figure 6. Odds ratios with 95% confidence intervals for comorbidities 
adjusted for age and sex.  Never smokers was the referent group. P values 
indicate significance of the hazard ratios compared to never smokers. 
Outcomes 
There were 1749 deaths (9.0 %) over a mean follow-up of 12.4 ± 5.0 years.  
Consistent with exclusion of baseline CVD and residence in a state 
(Minnesota) with overall low CV death rates, cancer death was actually more 
common than CV deaths in our study group.  Mortality in the never smokers 
(referent) was 6.2%. Figure 7 shows the Cox regression analysis for total, 
CV and cancer mortality adjusted for age, sex, diabetes, hypertension and 
obesity.   
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Figure 7. Hazard ratios with 95% confidence intervals for total, CV and 
cancer death adjusted for age, sex, diabetes, obesity and hypertension. Never 
smokers was the referent group. P values indicate significance of the hazard 
ratios compared to never smokers. 
Never smokers formed the referent group for all analyses.  Total, CV and 
cancer death rates were only slightly increased in past smokers versus never 
smokers but were much higher in current smokers. There was no overlap 
between confidence intervals in any group. The hazard ratio was the highest 
for CV mortality in current smokers (2.95; 95% CI: 2.3 – 3.8). We analyzed 
the effect of CRF on mortality in the smoking groups (Figure 8).  Total 
mortality in never, past and current smokers was inversely related to CRF as 
shown on Figure 8. Never smokers with normal CRF (FAC ≥ 100%) formed 
the referent group for the first part of the analysis; then we performed the 
comparisons within smoking groups using the normal CRF for each specific 
smoking group as the referent.  Compared to the normal CRF/never smokers, 
all groups except the normal CRF/past smokers showed increased risk of all 
mortality.  The current smokers with poor CRF had the highest mortality 
(hazard ratio: 5.3 with 95% confidence limits [4.3 – 6.5]). 
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Figure 8. Hazard ratios with 95% confidence intervals for total mortality 
(3a), CV (CV) mortality (3b), and cancer mortality (3c) according to 
smoking status and level of CRF (CRF) adjusted for age, sex, diabetes, 
hypertension, and obesity.  P values in the bars indicate the significance of 
hazard ratios compared to referent group.  Differences within the smoking 
groups indicated by dashed lines. P values indicate significance of the hazard 
ratios compared to normal CRF groups in never, past and current smokers. 
CRF = cardiorespiratory fitness 
 
We did a secondary analysis using all never smokers as a referent group (not 
showing on the figure) and found that fit (CRF ≥ 100%) current smokers did 
not have increased mortality versus all never smokers (HR = 0.98; 99% CI: 
0.67 - 1.50), and mortality of fit past smokers was actually lower versus all 
never smokers (HR = 0.80; 99% CI: 0.64 - 0.95). We analyzed CV and cancer 
mortality as well. The pattern of cancer mortality was quite similar compared 
to total mortality, but the effect of CRF was more pronounced regarding the 
CV mortality between each group.  The hazard ratio for total mortality in 
current smokers was 5.3 with 95% confidence limits [4.3 – 6.5], while the 
hazard ratio for CV mortality in current smokers was 7.1 with 95% 
confidence limits [4.9 – 10.3].  
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CONCLUSIONS 
Our investigations have covered a broad approach to the clinical problem of 
establishing CV risk. The continuum of individuals studied ranges from 
young athletes and master athletes with high levels of CV fitness, who would 
mostly be at the lowest possible risk level if not for their high intensity 
training and competitive performance, all the way to adults who are current 
smokers with very much reduced levels of CRF and at very high risk for total 
and CV mortality. A number of evaluative techniques – all involving some 
aspect of ECG – have been explored: the simple 12-lead resting ECG; long-
term ECG recordings by Holter monitoring with special analysis of HRV; 
and exercise ECG. Although imaging now dominates the practice of 
cardiology, we show that there continues to be great power in the simple 
things – the resting ECG, the pattern of response of the HR, and the ability 
to perform aerobic exercise. 
According to our results, the athletes’ ECG data showed a significant 
physiological electrical and structural adaptation but in some cases 
potentially pathological abnormalities may be revealed.  In our study of a 
composite sample of asymptomatic Hungarian athletes, we have found no 
underlying structural heart disease either in individuals with ECG 
abnormalities. However, with a thorough evaluation of ECG, we could 
recognize athletes as being at a potentially higher risk, therefore we suggest 
regular CV follow-up. Our study is a representative sample of Hungarian 
athletic ECG changes, therefore we believe that an exact definition and 
widespread knowledge of athletic ECG is essential in early recognition of 
high risk athletes.  
Athletic adaptation can also be investigated with long-term ECG recording. 
On a routine Holter ECG recording we can get important information about 
the status of the autonomic nervous system. In athletes, long-term time-
domain parameters of HRV were proved to be higher compared to controls. 
This indicates that autonomic adaptation is a part of athletic adaptation 
reflecting a dominant parasympathetic tone. Moreover, these parameters 
vary according to sports modality referring to the role of autonomic system 
in the sport-specific adaptation of the heart. According to our findings, 
autonomic adaptation of athletes is permanent, because the elevated HRV 
values remain unchanged in master athletes. As we have determined normal 
athletic values, therefore using our lower cut off values may also detect 
athletes at high CV risk based on decreased autonomic adaptation.  
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ECG recording during exercise testing is another important method of risk 
assessment. In our studies we focused on the prognostic parameters from the 
exercise test, and we have also identified the clinical factors which modify 
these prognostic parameters. HR responses to exercise are age and sex 
related. Women have higher resting HR rate, lower HR reserve and lower 
peak HR compared to men. Observing these sex differences brought up the 
idea that predicted equation in women may have to be different. In our large 
cohort, after eliminating factors negatively affecting peak HR, the equation 
predicting peak HR in men was nearly identical to the traditional formula but 
peak HR in women had a lower intercept and decreased more slowly with 
age. A separate formula for peak HR in women seems to be appropriate.  
Exercise HR responses are different in many pathological conditions. In our 
research we have focused on the effects of smoking. Although past smokers 
showed higher rates of comorbidities (obesity, diabetes, hypertension, and 
low CRF), their mortality was only mildly increased compared to never 
smokers. Current smoking, however, carried a high mortality risk despite 
lack on an increase in CV comorbidites versus never smokers. These data 
suggest that quitting smoking is beneficial despite increased comorbidities. 
Exercise may potentially mitigate the risk of both comorbidities and death in 
those who quit smoking. Overall, we can conclude that exercise testing is an 
important diagnostic method and it has potential important prognostic value 
to detect patients at high risk.  
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